TECNOTREE
26.2.2024 11:54:29 CET | Business Wire | Press release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, is thrilled to announce a ground-breaking partnership with BytePlus, the enterprise arm of Bytedance, to revolutionise wholesale enterprise monetization through Tecnotree Moments campaign management for CSPs. This collaboration marks a significant milestone in B2B2X digital ecosystem management, showcasing a bold step towards enhanced AI and API monetization strategies for CSPs worldwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240226979665/en/
(Graphic: Business Wire)
Tecnotree Moments, leveraging its expertise in telco partner ecosystem monetisation, has partnered with Byteplus, in digital media and distribution, introducing cutting-edge solutions that drive value and growth for CSPs. The partnership underscores Tecnotree Moments's commitment to delivering AI solutions such as channel personalization and interactive experiences on a unified telecom led customer data platform, enabling CSPs to unlock new enterprise revenue streams through AIML and Multi-AIML model management for goal based learning delivering hyper-personalisation in video, music and ARVR advertising for the 3 dimensional 5G world.
The reseller API integration will see Tecnotree Moments reselling Byteplus’s advanced media technology on Moments’ campaign and marketplace to a ecosystem of digital services partners through CSPs. Tecnotree will be integrating wholesale advertising, content personalisation, and AIML recommendation models, to help CSPs in B2B2X enterprise monetisation across telecom, social media and digital channels. The comprehensive monetization suite, while enhancing customer experience will unlock new revenue streams for Telcos beyond data bundling, empowering CSPs to maximize revenue opportunities through Cost Per Click (CPC), Cost Per Mille (CPM) models and other cloud based subscription models for advertising.
Commenting on the partnership, Prianca Ravichander, CMO and Global Head of Partnerships of Tecnotree Corporation, said, “The 5G AI future is 3 dimensional with the digital landscape rapidly evolving, there is an opportunity to help CSPs monetize hyper-personalisation for enterprises on the Tecnotree Moments communication as a service platform. We are thrilled about the collaboration and its potential to reshape channel personalisation through telcos. By combining Tecnotree Moments’ channel personalisation platform for CSPs with Byteplus’s advanced creator tools and content recommendation technology for guaranteed uplift, we aim to empower creators, enterprises and telcos to thrive in the new digital economy.”
Charlie Sung, Global Head Partnership & Ecosystem, ByteDance and BytePlus said "Our collaboration with Tecnotree Moments represents a significant step forward in our mission to revolutionize digital monetization and our commitment to the region. Together, we look forward to empowering CSPs with innovative solutions, capitalize on the growing demand for personalization, and position ourselves for success in today’s digital economy”
About Tecnotree
Tecnotree is a 5G-ready digital Business Support System (BSS) player, with AI/ML capabilities and multi-cloud extensibility. Tecnotree leads the way on the TM Forum Open API Conformance with 59 certified Open APIs including 9 real-world open APIs, a testament to the company's commitment to excellence, and continuously striving to deliver differentiated experiences and services to both CSPs and DSPs. Our agile and open-source digital BSS Stack comprises the full range (order-to-cash) of business processes and subscription management for telecom and other digital services industries creating opportunities beyond connectivity. Tecnotree also provides Fintech and B2B2X multi-experience digital marketplace to its subscriber base through the Tecnotree Moments platform to empower digitally connected communities across gaming, health, education, OTT, and other vertical ecosystems. Tecnotree is listed on the Helsinki Nasdaq (TEM1V).
About BytePlus
Byteplus is designed to help businesses grow and improve efficiency by providing them with cutting-edge technology solutions that are powered by ByteDance's vast knowledge and expertise accumulated through serving billions of users globally. The platform offers a range of services, including personalized recommendation algorithms, AI technologies, machine learning, video and image recognition, cloud data warehouse and content delivery. With these tools, businesses can improve their customer experience, enhance their products and services, and gain a competitive edge in the market.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240226979665/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom